Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Total ginsenosides refer to a standardized mixture of steroid-like saponins extracted from the roots, stems, or leaves of *Panax ginseng*. These compounds are the primary bioactive constituents responsible for the pharmacological effects of ginseng, particularly in cardiovascular and metabolic health. In the context of cardiovascular therapy, total ginsenosides exhibit cardioprotective properties by enhancing myocardial oxygen supply, reducing oxidative stress, and inhibiting platelet aggregation. They are known to promote vasodilation through the activation of nitric oxide synthase (NOS) and modulate calcium signaling by inhibiting L-type calcium channels. China Pharmaceutical Research and Development Center Co., Ltd. has developed specific preparations of total ginsenosides for the treatment of chronic stable angina pectoris, aiming to alleviate symptoms and improve cardiac function in patients with coronary heart disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on total ginsenosides.